Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
Authors' conclusion
Virtually delivered treatment combining telemedicine and a behavioral program tailored for long-acting AOMs demonstrated clinically significant improvements in weight, BP, diet, and activity over 24 weeks.
Study context
- Population
- Participants from a telehealth medical obesity program; mean age 44.1, 91% female, 81% White, mean weight 102.8 kg
- Participants
- 180 participants
- Outcome
- Weight loss
- Follow-up
- 24 weeks
Methodological detailstelehealth, virtual behavioral program
- Telehealth
- Virtual behavioral program
Main finding
As reported in the abstract
Weight loss at 24 weeks (SD 6.9%; p < 0.0001)
12.3%
Further findings
Weight loss · 12 weeks
- Weight loss at 12 weeks (SD 5.2%)
- 7.2%
Mean blood pressure (BP) · baseline, 12 and 24 weeks
- Mean BP at baseline (SD 17.2/12.2)
- 131.0/83.8
- Mean BP at 12 weeks (SD 13.7/10.1)
- 122.5/78.7
- Mean BP at 24 weeks (SD 13.5/10.6; p < 0.0001)
- 120.0/78.2
Eating habits, diet quality and activity
- Participants significantly improved their eating habits, diet quality, and activity
Safety
- Side effects were markedly lower than in previously reported trials
Original publication
Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study. Obesity (Silver Spring). Published 18 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →